ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 104 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2018. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $79,500 | -72.0% | 50,000 | -83.3% | 0.00% | -75.0% |
Q3 2022 | $284,000 | -2.1% | 299,000 | +23.6% | 0.01% | +14.3% |
Q2 2022 | $290,000 | -8.5% | 242,000 | 0.0% | 0.01% | +16.7% |
Q1 2022 | $317,000 | -73.0% | 242,000 | +8.2% | 0.01% | -60.0% |
Q1 2019 | $1,172,000 | +96.6% | 223,600 | +18.2% | 0.02% | +87.5% |
Q4 2018 | $596,000 | -47.9% | 189,200 | 0.0% | 0.01% | -27.3% |
Q3 2018 | $1,145,000 | +14.2% | 189,200 | 0.0% | 0.01% | +10.0% |
Q2 2018 | $1,003,000 | -8.6% | 189,200 | 0.0% | 0.01% | -16.7% |
Q1 2018 | $1,097,000 | +70.3% | 189,200 | +2.9% | 0.01% | +71.4% |
Q4 2017 | $644,000 | -4.0% | 183,900 | 0.0% | 0.01% | -12.5% |
Q3 2017 | $671,000 | +45.9% | 183,900 | 0.0% | 0.01% | +33.3% |
Q2 2017 | $460,000 | -7.4% | 183,900 | 0.0% | 0.01% | 0.0% |
Q1 2017 | $497,000 | -52.8% | 183,900 | -49.4% | 0.01% | -57.1% |
Q4 2016 | $1,054,000 | -24.7% | 363,400 | +6.8% | 0.01% | -33.3% |
Q3 2016 | $1,399,000 | +218.7% | 340,297 | +144.7% | 0.02% | +200.0% |
Q2 2016 | $439,000 | – | 139,039 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sonic Fund II, L.P. | 6,552,068 | $14,218,000 | 8.03% |
Versant Venture Management, LLC | 5,068,233 | $10,998,000 | 4.55% |
K2 PRINCIPAL FUND, L.P. | 1,653,874 | $3,589,000 | 0.29% |
RTW INVESTMENTS, LP | 7,483,757 | $16,240,000 | 0.24% |
Avoro Capital Advisors LLC | 6,950,000 | $15,082,000 | 0.24% |
Artal Group S.A. | 3,000,000 | $6,510,000 | 0.15% |
ALGERT GLOBAL LLC | 231,490 | $502,000 | 0.07% |
Virtus ETF Advisers LLC | 57,768 | $125,000 | 0.06% |
Pinz Capital Management, LP | 53,600 | $116,000 | 0.05% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 100,000 | $217,000 | 0.05% |